Japan Pharmaceuticals & Healthcare Report Q3 2013 - New Study Released
Japan remains the most attractive market in the Asia Pacific, due to the ageing and affluent population and strong regulatory conditions. In particular, we highlight that the slowing economy poses opportunities for generic drug players looking to expand in the country. Meanwhile, domestic firms will continue to expand overseas (especially in emerging markets) in order to maintain revenue growth.
View full press release